Compounds > naltrexone

naltrexone and Carcinoma, Hepatocellular

naltrexone has been researched along with Carcinoma, Hepatocellular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chia, BK; Tey, HL1
Harlos, MS; Hohl, CM; Wong, JK1

Other Studies

2 other study(ies) available for naltrexone and Carcinoma, Hepatocellular

ArticleYear
Metastatic hepatocellular carcinoma with paraneoplastic itch: effective treatment with naltrexone.
    Journal of drugs in dermatology : JDD, 2014, Volume: 13, Issue:12

    Topics: Carcinoma, Hepatocellular; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Neoplasm Metastasis; Paraneoplastic Syndromes; Pruritus; Treatment Outcome

2014
Methylnaltrexone to Palliate Pruritus in Terminal Hepatic Disease.
    Journal of palliative care, 2015, Volume: 31, Issue:2

    Topics: Aged; Carcinoma, Hepatocellular; Fatal Outcome; Female; Gallbladder Neoplasms; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Pain Measurement; Pruritus; Quaternary Ammonium Compounds; Terminal Care

2015